These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1282707)

  • 1. High percentage acrylamide gels improve resolution in SSCP analysis.
    Savov A; Angelicheva D; Jordanova A; Eigel A; Kalaydjieva L
    Nucleic Acids Res; 1992 Dec; 20(24):6741-2. PubMed ID: 1282707
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of novel and rare mutations in exon 4 of the cystic fibrosis gene by SSCP.
    Shackleton S; Beards F; Harris A
    Hum Mol Genet; 1992 Sep; 1(6):439-40. PubMed ID: 1284529
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene.
    Ravnik-Glavac M; Glavac D; Dean M
    Hum Mol Genet; 1994 May; 3(5):801-7. PubMed ID: 7521710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of three novel mutations in the CFTR gene using temperature-optimized non-radioactive conditions for SSCP analysis.
    Grade K; Grunewald I; Graupner I; Behrens F; Coutelle C
    Hum Genet; 1994 Aug; 94(2):154-8. PubMed ID: 7519167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non radioactive single-strand conformation polymorphism (SSCP) analysis of exon 11 of the CFTR gene using the Pharmacia PhastSystem.
    Cormier-Daire V; Clavel C; Polette M; Doco M; Boutterin MC; Binninger I; Birembaut P
    Pathol Biol (Paris); 1993 Oct; 41(8):713-5. PubMed ID: 8290318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of genetic diseases by asymmetric-PCR SSCP and ethidium bromide staining: application to neurofibromatosis and cystic fibrosis.
    Lázaro C; Estivill X
    Mol Cell Probes; 1992 Oct; 6(5):357-9. PubMed ID: 1282203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel CFTR mutation, 4035delA, detected by non-radioactive SSCP analysis.
    Reiss J; Lenz U; Rininsland F; Ballhausen P; Drews D; Posselt HG
    Hum Genet; 1992 Nov; 90(3):303-4. PubMed ID: 1283151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Zielenski J; Markiewicz D; Chen HS; Schappert K; Seller A; Durie P; Corey M; Tsui LC
    Hum Mutat; 1995; 5(1):43-7. PubMed ID: 7537150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for CF mutations in adult cystic fibrosis patients with a directed and optimized SSCP strategy.
    Ravnik-Glavac M; Glavac D; Chernick M; di Sant'Agnese P; Dean M
    Hum Mutat; 1994; 3(3):231-8. PubMed ID: 7517265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid phase fluorescent sequencing of the CFTR gene.
    Cuppens H; Cassiman JJ
    Methods Mol Biol; 2001; 167():63-88. PubMed ID: 11265322
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonisotopic detection of mutations using a modified single-strand conformation polymorphism analysis.
    Weidner J; Eigel A; Horst J; Köhnlein W
    Hum Mutat; 1994; 4(1):55-6. PubMed ID: 7524914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new polymorphism in exon 7 of the cystic fibrosis transmembrane regulator (CFTR) gene.
    Petreska L; Koceva S; Gordova-Muratovska A; Efremov GD
    Hum Genet; 1995 Apr; 95(4):465-6. PubMed ID: 7535746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
    Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
    Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new mutations detected by single-strand conformation polymorphism analysis in cystic fibrosis from Russia.
    Ivaschenko TE; Baranov VS; Dean M
    Hum Genet; 1993 Mar; 91(1):63-5. PubMed ID: 7681034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-gel PAGE for enhanced resolution of polymerase chain reaction detection of delta F508 deletion in cystic fibrosis.
    Makowski GS; Aslanzadeh J; Hopfer SM
    Clin Chem; 1993 Oct; 39(10):2204-5. PubMed ID: 7691446
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous detection of delta F508, G542X, N1303K and 1717-1G-->A mutations in cystic fibrosis by capillary electrophoresis in polymer networks.
    Gelfi C; Righetti PG; Magnani C; Cremonesi L; Ferrari M
    Clin Chim Acta; 1994 Sep; 229(1-2):181-9. PubMed ID: 7527312
    [No Abstract]   [Full Text] [Related]  

  • 17. SSCP/heteroduplex analysis.
    Wallace AJ
    Methods Mol Biol; 2002; 187():151-63. PubMed ID: 12013742
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel frameshift mutation in exon 4 of CFTR gene.
    Ivaschenko T; Bakay M; Baranov V
    Hum Mutat; 1995; 5(2):184-5. PubMed ID: 7538377
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved single-strand conformation polymorphism analysis by asymmetric polymerase chain reaction with end-labeled primers.
    Russell GC
    Genet Anal Tech Appl; 1994; 11(1):24-7. PubMed ID: 8060678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel frame-shift mutation in exon 4 of the cystic fibrosis gene (435insA) demonstrates the ambiguity of restriction analysis for mutation screening.
    Kälin N; Dörk T; Bozon D; Tümmler B
    Hum Mol Genet; 1992 Oct; 1(7):545-6. PubMed ID: 1284889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.